These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 13374539)

  • 1. [Study of urinary elimination of iron by a chelate (edathamil calcium) in hemochromatosis].
    AVRIL J; DREUX C; KLOTZ HP; PARIENTE R
    Bull Mem Soc Med Hop Paris; 1956 Oct; 72(24-25):724-7. PubMed ID: 13374539
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of the effect of Fe-3-Specific, versenol, and calcium disodium versenate on urinary iron excretion in a patient with hemochromatosis.
    MCMAHON FG
    J Lab Clin Med; 1956 Oct; 48(4):589-602. PubMed ID: 13367597
    [No Abstract]   [Full Text] [Related]  

  • 3. A study of the effect of disodium calcium versenate (Ca EDTA) on iron excretion in man.
    FIGUEROA WG; ADAMS WS; DAVIS FW; BASSETT SH
    J Lab Clin Med; 1955 Oct; 46(4):534-43. PubMed ID: 13263733
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of ethylenediaminetetraacetic acid calcium on the levels of blood iron & urinary iron in 2 cases of idiopathic hemochromatosis].
    CRISMER R; DURIEUX M; DREZE C; DUBOIS J
    Acta Gastroenterol Belg; 1958 Nov; 21(11):704-13. PubMed ID: 13605575
    [No Abstract]   [Full Text] [Related]  

  • 5. Urinary mercury and lead excretion in a case of mercurialism; differential excretion after administration of edathamil calcium and dimercaprol.
    BELL RF; GILLILAND JC; DUNN WS
    AMA Arch Ind Health; 1955 Mar; 11(3):231-3. PubMed ID: 14349410
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic & diagnostic value of iron in urine induced by chelators in hemochromatosis].
    GIRARD M; CREYSSEL R; PANSU C; BEL A; GOLHEN A
    Lyon Med; 1958 Mar; 90(11):415-26. PubMed ID: 13540353
    [No Abstract]   [Full Text] [Related]  

  • 7. THE NEW CHELATING AGENT CA-DTPA IN THE TREATMENT OF PRIMARY HAEMOCHROMATOSIS.
    KEMBLE JV
    Guys Hosp Rep; 1964; 113():68-73. PubMed ID: 14114732
    [No Abstract]   [Full Text] [Related]  

  • 8. [Post-desferrioxamine urinary iron in iron-overload states].
    Santiago Corchado M; Ribas Ozonas B
    Rev Clin Esp; 1970 Jul; 118(2):151-8. PubMed ID: 5486372
    [No Abstract]   [Full Text] [Related]  

  • 9. [Trilonometric determination of calcium and magnesium in the cerebrospinal fluid and other biological fluids].
    SIUDMAK NV; GUITUR MI; KHUDOSHINA EM
    Lab Delo; 1962 Sep; 8():55-9. PubMed ID: 13977787
    [No Abstract]   [Full Text] [Related]  

  • 10. Four-hour measurement of urinary iron excretion after deferoxine treatment: a rapid, simple method for study of iron excretion.
    Bonkovsky HL; Weber R; Aaron L
    Am J Gastroenterol; 1990 May; 85(5):554-7. PubMed ID: 2337058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative urinary coproporphyrin excretion and its relation to edathamil calcium disodium administration in children with acute lead intoxication.
    CHISOLM JJ; HARRISON HE
    J Clin Invest; 1956 Oct; 35(10):1131-8. PubMed ID: 13367209
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of ascorbic acid on desferrioxamine-induced urinary iron excretion in idiopathic hemochromatosis.
    Conte D; Brunelli L; Ferrario L; Mandelli C; Quatrini M; Velio P; Bianchi PA
    Acta Haematol; 1984; 72(2):117-20. PubMed ID: 6437113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of oral edathamil calcium-disodium on urinary and fecal lead excretion; comparative excretory studies with intravenous therapy.
    BELL RF; GILLILAND JC; BOLAND JR; SULLIVAN BR
    AMA Arch Ind Health; 1956 Apr; 13(4):366-71. PubMed ID: 13301069
    [No Abstract]   [Full Text] [Related]  

  • 14. [Edathamil calcium-disodium in diagnosis of occupational lead poisoning].
    ZAMBRANO A; ROSSI L; MANTOVANO S
    Folia Med (Napoli); 1955 Nov; 38(11):1248-59. PubMed ID: 13305642
    [No Abstract]   [Full Text] [Related]  

  • 15. [Employment of chelating agents of the Calcium E.D.T.A. type during the course of various excessive blood iron conditions].
    LAMACHE A; BOUREL M; VIVIEN P; CORMIER M; LENOIR P; AZARD C; DELAHAYE D
    Sem Med Prof Med Soc; 1957 Feb; 33(7):295-8. PubMed ID: 13421822
    [No Abstract]   [Full Text] [Related]  

  • 16. A study of the prolonged intake of small amounts of ethylenediaminetetraacetate on the utilization of low dietary levels of calcium and iron by the rat.
    HAWKINS WW; LEONARD VG; MAXWELL JE; RASTOGI KS
    Can J Biochem Physiol; 1962 Mar; 40():391-5. PubMed ID: 13905524
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of the prolonged intake of ethylenediaminetetraacetate on the utilization of calcium and iron by the rat.
    LARSEN BA; HAWKINS WW; LEONARD VG; ARMSTRONG JE
    Can J Biochem Physiol; 1960 Aug; 38():813-7. PubMed ID: 14414260
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral administration of edathamil calcium disodium (calcium disodium versenate).
    PAGNOTTO LD; ELKINS HB; BAYKA I
    AMA Arch Ind Health; 1958 Jan; 17(1):29-33. PubMed ID: 13486951
    [No Abstract]   [Full Text] [Related]  

  • 19. PIPERAZINE calcium edathamil.
    J Am Med Assoc; 1956 Oct; 162(7):658. PubMed ID: 13366656
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased urinary excretion of 8-iso-prostaglandin F2alpha in patients with HFE-related hemochromatosis: a case-control study.
    Kom GD; Schwedhelm E; Nielsen P; Böger RH
    Free Radic Biol Med; 2006 Apr; 40(7):1194-200. PubMed ID: 16545687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.